Literature DB >> 15077182

Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.

Mandayam O Nandan1, Hong S Yoon, Weidong Zhao, Lillian A Ouko, Sengthong Chanchevalap, Vincent W Yang.   

Abstract

Previous studies indicate that Krüppel-like factor 5 (KLF5), also known as intestinal-enriched Krüppel-like factor (IKLF), is a positive regulator of cell proliferation and gives rise to a transformed phenotype when overexpressed. Here we demonstrate that levels of KLF5 transcript and protein are significantly elevated in oncogenic H-Ras-transformed NIH3T3 cells. These cells display an accelerated rate of proliferation in both serum-containing and serum-deprived media and form anchorage-independent colonies in soft agar assays. H-Ras-transformed cells also contain elevated mitogen-activated protein kinase (MAPK) activity. When treated with inhibitors of MEK (MAPK kinase), H-Ras-transformed cells lose their growth advantage and no longer form colonies. Significantly, levels of KLF5 transcript and protein are substantially reduced in H-Ras-transformed cells treated with MEK inhibitors. Moreover, inhibition of KLF5 expression in H-Ras-transformed cells with KLF5-specific small interfering RNA (siRNA) leads to a decreased rate of proliferation and a significant reduction in colony formation. H-Ras-transformed cells also contain elevated levels of Egr1 that are diminished by MEK inhibitors. Inhibition of Egr1 by siRNA results in a reduced level of KLF5, indicating that Egr1 mediates the inductive action of MAPK on KLF5. Lastly, KLF5 activates expression of cyclin D1. These findings indicate that the increased expression of KLF5 in H-Ras-transformed cells is secondary to increased MAPK activity from H-Ras overexpression and that the elevated level of KLF5 is in part responsible for the proproliferative and transforming activities of oncogenic H-Ras. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077182      PMCID: PMC1351030          DOI: 10.1038/sj.onc.1207397

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

Review 1.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors.

Authors:  S Philipsen; G Suske
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy.

Authors:  D R DeSilva; E A Jones; M F Favata; B D Jaffee; R L Magolda; J M Trzaskos; P A Scherle
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

3.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.

Authors:  J J Liu; J R Chao; M C Jiang; S Y Ng; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

Review 4.  The ins and outs of Raf kinases.

Authors:  G Daum; I Eisenmann-Tappe; H W Fries; J Troppmair; U R Rapp
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

5.  Activation of p70/p85 S6 kinase by a pathway independent of p21ras.

Authors:  X F Ming; B M Burgering; S Wennström; L Claesson-Welsh; C H Heldin; J L Bos; S C Kozma; G Thomas
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

6.  12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells.

Authors:  M Y El-Shemerly; D Besser; M Nagasawa; Y Nagamine
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  Induction of cyclin D1 overexpression by activated ras.

Authors:  J Filmus; A I Robles; W Shi; M J Wong; L L Colombo; C J Conti
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

8.  Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.

Authors:  R Marais; Y Light; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

9.  RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

Authors:  J Y Chen; S Penco; J Ostrowski; P Balaguer; M Pons; J E Starrett; P Reczek; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.

Authors:  K W Muszynski; F W Ruscetti; G Heidecker; U Rapp; J Troppmair; J M Gooya; J R Keller
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  73 in total

1.  Krüppel-like factor 5 protects against dextran sulfate sodium-induced colonic injury in mice by promoting epithelial repair.

Authors:  Beth B McConnell; Samuel S Kim; Agnieszka B Bialkowska; Ke Yu; Shanthi V Sitaraman; Vincent W Yang
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

2.  ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer.

Authors:  Ainara Ruiz de Sabando; Chao Wang; Yuanjun He; Mónica García-Barros; Julie Kim; Kenneth R Shroyer; Thomas D Bannister; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Mol Cancer Ther       Date:  2015-11-30       Impact factor: 6.261

3.  KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression.

Authors:  Mandayam O Nandan; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 4.  The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology.

Authors:  Beth B McConnell; Amr M Ghaleb; Mandayam O Nandan; Vincent W Yang
Journal:  Bioessays       Date:  2007-06       Impact factor: 4.345

Review 5.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

6.  Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5.

Authors:  James X Du; C Chris Yun; Agnieszka Bialkowska; Vincent W Yang
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

Review 7.  Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation.

Authors:  Amr M Ghaleb; Mandayam O Nandan; Sengthong Chanchevalap; W Brian Dalton; Irfan M Hisamuddin; Vincent W Yang
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

8.  Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.

Authors:  Mandayam O Nandan; Sengthong Chanchevalap; W Brian Dalton; Vincent W Yang
Journal:  FEBS Lett       Date:  2005-08-29       Impact factor: 4.124

Review 9.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

10.  Kruppel-like factor 5 shows proliferation-specific roles in vascular remodeling, direct stimulation of cell growth, and inhibition of apoptosis.

Authors:  Toru Suzuki; Daigo Sawaki; Kenichi Aizawa; Yoshiko Munemasa; Takayoshi Matsumura; Junichi Ishida; Ryozo Nagai
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.